X‐Ray‐Controlled Generation of Peroxynitrite Based on Nanosized LiLuF4:Ce3+ Scintillators and their Applications for Radiosensitization

Peroxynitrite (ONOO−), the reaction product derived from nitric oxide (NO) and superoxide (O2−•), is a potent oxidizing and nitrating agent that modulates complex biological processes and promotes cell death. Therefore, it can be expected that the overproduction of ONOO− in tumors can be an efficient approach in cancer therapy. Herein, a multifunctional X‐ray‐controlled ONOO− generation platform based on scintillating nanoparticles (SCNPs) and UV‐responsive NO donors Roussin's black salt is reported, and consequently the mechanism of their application in enhanced therapeutic efficacy of radiotherapy is illustrated. Attributed to the radioluminescence and high X‐ray‐absorbing property of SCNPs, the nanocomposite can produce NO and O2−• simultaneously when excited by X‐ray irradiation. Such simultaneous release of NO and O2−• ensures the efficient X‐ray‐controlled generation of ONOO− in tumors. Meanwhile, the application of X‐rays as the excitation source can achieve better penetration depth and induce radiotherapy in this nanotherapeutic platform. It is found that the X‐ray‐controlled ONOO−‐generation platform can efficiently improve the radiotherapy efficiency via directly damaging DNA, downregulating the expression of the DNA‐repair enzyme, and overcoming the hypoxia‐associated resistance in radiotherapy. Therefore, this SCNP‐based platform may provide a new combinatorial strategy of ONOO− and radiotherapy to improve cancer treatment.

[1]  R. Hock,et al.  NOBF4-Functionalized Au-Fe3O4 Nanoheterodimers for Radiation Therapy: Synergy Effect Due to Simultaneous Reactive Oxygen and Nitrogen Species Formation. , 2018, ACS applied materials & interfaces.

[2]  Hao Wang,et al.  Synthesis of Self-Assembled Porphyrin Nanoparticle Photosensitizers. , 2018, ACS nano.

[3]  M. Trujillo,et al.  Biochemistry of Peroxynitrite and Protein Tyrosine Nitration. , 2018, Chemical reviews.

[4]  C. Benes,et al.  PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53 , 2018, Oncogene.

[5]  S. Obregón,et al.  Direct evidence of the photocatalytic generation of reactive oxygen species (ROS) in a Bi2W2O9 layered-structure. , 2017, Journal of colloid and interface science.

[6]  T. Hyeon,et al.  Continuous O2-Evolving MnFe2O4 Nanoparticle-Anchored Mesoporous Silica Nanoparticles for Efficient Photodynamic Therapy in Hypoxic Cancer. , 2017, Journal of the American Chemical Society.

[7]  Zhanjun Gu,et al.  Near infrared light triggered nitric oxide releasing platform based on upconversion nanoparticles for synergistic therapy of cancer stem-like cells. , 2017, Science bulletin.

[8]  Xiangfeng Liu,et al.  Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response. , 2017, ACS nano.

[9]  Kai Yang,et al.  Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy , 2017, Advanced materials.

[10]  David A Jaffray,et al.  Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements☆ , 2017, Advanced drug delivery reviews.

[11]  Yuliang Zhao,et al.  Nitric oxide-generating l-cysteine-grafted graphene film as a blood-contacting biomaterial. , 2016, Biomaterials science.

[12]  W. Cai,et al.  Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy. , 2016, ACS nano.

[13]  Paul Lecoq,et al.  Development of new scintillators for medical applications , 2016 .

[14]  Qianjun He,et al.  X-ray Radiation-Controlled NO-Release for On-Demand Depth-Independent Hypoxic Radiosensitization. , 2015, Angewandte Chemie.

[15]  W. McBride,et al.  Opportunities and challenges of radiotherapy for treating cancer , 2015, Nature Reviews Clinical Oncology.

[16]  Thierry Bastogne,et al.  Nanoparticles for Radiation Therapy Enhancement: the Key Parameters , 2015, Theranostics.

[17]  Yuliang Zhao,et al.  Controllable Generation of Nitric Oxide by Near‐Infrared‐Sensitized Upconversion Nanoparticles for Tumor Therapy , 2015 .

[18]  Feng Liu,et al.  Nanoscintillator-mediated X-ray inducible photodynamic therapy for in vivo cancer treatment. , 2015, Nano letters.

[19]  Dalong Ni,et al.  Marriage of scintillator and semiconductor for synchronous radiotherapy and deep photodynamic therapy with diminished oxygen dependence. , 2015, Angewandte Chemie.

[20]  Yuliang Zhao,et al.  TPGS-stabilized NaYbF4:Er upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance. , 2015, Biomaterials.

[21]  Ian M. Kennedy,et al.  NaGdF4:Eu3+ Nanoparticles for Enhanced X-ray Excited Optical Imaging , 2014, Chemistry of materials : a publication of the American Chemical Society.

[22]  Ping Huang,et al.  Lanthanide-doped LiLuF(4) upconversion nanoprobes for the detection of disease biomarkers. , 2014, Angewandte Chemie.

[23]  S. Anant,et al.  Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer , 2013 .

[24]  Si-Shen Feng,et al.  Vitamin E TPGS as a molecular biomaterial for drug delivery. , 2012, Biomaterials.

[25]  V. Chani,et al.  Scintillation properties of Ce-doped LuLiF4 and LuScBO3 , 2011 .

[26]  Masaki Misawa,et al.  Generation of reactive oxygen species induced by gold nanoparticles under x-ray and UV Irradiations. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[27]  Fiona A. Stewart,et al.  Strategies to improve radiotherapy with targeted drugs , 2011, Nature Reviews Cancer.

[28]  Geoffrey A Ozin,et al.  Synthesis of ligand-free colloidally stable water dispersible brightly luminescent lanthanide-doped upconverting nanoparticles. , 2011, Nano letters.

[29]  W. Koppenol,et al.  Distance-dependent diffusion-controlled reaction of •NO and O2•- at chemical equilibrium with ONOO-. , 2010, The journal of physical chemistry. B.

[30]  S. Sortino Light-controlled nitric oxide delivering molecular assemblies. , 2010, Chemical Society reviews.

[31]  D. Verellen,et al.  Hypoxic tumor cell radiosensitization through nitric oxide. , 2008, Nitric oxide : biology and chemistry.

[32]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[33]  Robert Almassy,et al.  Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. , 2004, Journal of the National Cancer Institute.

[34]  D. Wink,et al.  Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. , 2003, Free radical biology & medicine.

[35]  É. Szabó,et al.  Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. , 2003, Toxicology letters.

[36]  C. Szabó Multiple pathways of peroxynitrite cytotoxicity. , 2003, Toxicology letters.

[37]  C. Szabó,et al.  The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors , 2002, Pharmacological Reviews.

[38]  F. Agani,et al.  Role of nitric oxide in the regulation of HIF-1α expression during hypoxia , 2002 .

[39]  Xiaoping Liu,et al.  The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Silverman,et al.  Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) , 1999, Pharmaceutical Research.

[41]  S. Snyder,et al.  Poly (ADP-ribose) polymerase, nitric oxide and cell death. , 1999, Trends in pharmacological sciences.

[42]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[43]  I. Fridovich Superoxide Anion Radical (O·̄2), Superoxide Dismutases, and Related Matters* , 1997, The Journal of Biological Chemistry.

[44]  James B. Mitchell,et al.  Photochemistry of Roussin's Red Salt, Na2[Fe2S2(NO)4], and of Roussin's Black Salt, NH4[Fe4S3(NO)7]. In Situ Nitric Oxide Generation To Sensitize γ-Radiation Induced Cell Death1 , 1997 .

[45]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[46]  P Vaupel,et al.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.

[47]  J. Beckman Peroxynitrite versus Hydroxyl Radical: The Role of Nitric Oxide in Superoxide‐Dependent Cerebral Injury a , 1994, Annals of the New York Academy of Sciences.

[48]  C. Melcher,et al.  Cerium-doped lutetium oxyorthosilicate: a fast, efficient new scintillator , 1991, Conference Record of the 1991 IEEE Nuclear Science Symposium and Medical Imaging Conference.

[49]  B. Freeman,et al.  Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. , 1991, Archives of biochemistry and biophysics.

[50]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[52]  Hua He,et al.  Cancer Radiosensitizers. , 2018, Trends in pharmacological sciences.

[53]  M. Piccart,et al.  An update on PARP inhibitors—moving to the adjuvant setting , 2015, Nature Reviews Clinical Oncology.

[54]  Lin Zhu,et al.  Stimulus-responsive nanopreparations for tumor targeting. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[55]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[56]  Christian Pedrini,et al.  Optical and scintillation properties of Ce3+ doped LiYF4 and LiLuF4 crystals , 1997 .